Significant alterations of mycophenolate mofetil (MMF) pharmacokinetics in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Alternate dosing is required in AlloSCT compared to solid organ autograft recipients.

被引：0
|
作者：
Bessmertny, O [1 ]
Harrison, L [1 ]
Osunkwo, I [1 ]
Wischhover, C [1 ]
Garvin, J [1 ]
George, D [1 ]
Del Toro, G [1 ]
Bradley, MB [1 ]
Cairo, MS [1 ]
机构：
[1] Columbia Univ, Childrens Hosp New York Presbyterian, New York, NY 10027 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1622
引用
收藏
页码：418A / 419A
页数：2
相关论文
共 22 条
  • [1] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O.
    Hedgpeth, D.
    Shaw, L. M.
    Figurski, M.
    Satwani, P.
    Ayello, J.
    Roman, E.
    Bradley, B.
    George, D.
    Garvn, J.
    Bhatia, M.
    Wolownick, K.
    Foley, S.
    Hawkes, R.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 114 - 115
  • [2] Higher clearance rates of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O
    Roache, K
    Shaw, LM
    Figurski, M
    Satwani, P
    Ayello, J
    Roman, E
    Del Toro, G
    Bradley, B
    George, D
    Garvin, JH
    Bhatia, M
    Wolownik, K
    Foley, S
    Hawks, R
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 57 - 58
  • [3] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients are associated with significantly higher clearance
    Militano, O
    Roache, K
    Shaw, LM
    Figurski, M
    Satwani, P
    Ayello, J
    Wolownik, K
    Foley, S
    Hawkes, R
    Del Toro, G
    Bradley, MB
    George, D
    Garvin, J
    Bhatia, M
    Roman, L
    Cairo, MS
    BLOOD, 2005, 106 (11) : 518A - 518A
  • [4] PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) IN COMBINATION WITH TACROLIMUS IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS ≤ 12 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Figurski, M.
    Shaw, L.
    Geyer, M. B.
    Jacobson, J. S.
    Morris, F.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S191 - S191
  • [5] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Cheung, YK
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 103 - 103
  • [6] PHARMACOKINETICS (PK) OF IV AND PO MYCOPHENOLATE MOFETIL (MMF) IN AGE ADJUSTED PEDIATRIC AND ADOLESCENT ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS: SIGNIFICANTLY HIGHER CLss AND Vss IN PATIENTS <6 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Jin, Z.
    Figurski, M.
    Shaw, L.
    Moore, V
    Morris, E.
    Tallamy, B.
    van de Ven, C.
    Ayello, J.
    Baxter-Lowe, L. A.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 132 - 133
  • [7] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD.
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Skerrett, D
    Cairo, MS
    BLOOD, 2003, 102 (11) : 713A - 713A
  • [8] Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Garvin, J
    George, D
    Bradley, MB
    DelToro, G
    Wischhover, C
    Wolownik, K
    van de Ven, C
    Cheung, YK
    Cairo, MS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 528A - 528A
  • [9] MYCOPHENOLATE MOFETIL (MMF) [900 MG/M2 Q8H] IN COMBINATION WITH TACROLIMUS IS EFFECTIVE TO PREVENT ACUTE AND CHRONIC GVHD IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS
    Militano, Olga
    Mitchell, Daniel
    Ours, Christopher
    Morris, Erin
    Wolownik, Karen
    Foley, Sandi
    LeClere, Jennie
    Vandeven, Carmella
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S102 - S103
  • [10] Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic Gvhd Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
    Militano, Olga
    Mitchell, Daniel
    Ours, Christopher
    Morris, Erin
    Wolownik, Karen
    Foley, Sandra
    Leclere, Jennie
    van de Ven, Carmella
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S176 - S176
123